Articles dans des revues avec comité de lecture (98)

  1. 1. Verocq, C., Noël, J. C., Charry, M., Zindy, E., Rorive, S., Salmon, I., Decaestecker, C., & Catteau, X. (2024). Inverse correlation between the amounts of lymphocytic infiltrate and stroma in breast carcinoma. Heliyon, 10(22), e40295. doi:10.1016/j.heliyon.2024.e40295
  2. 2. Gleeson, P. J., Crippa, I. A., Sannier, A., Koopmansch, C., Bienfait, L., Allard, J., Sexton, D. D., Fontana, V., Rorive, S., Vincent, J. L., Creteur, J., & Taccone, F. (2023). Critically ill patients with acute kidney injury: clinical determinants and post-mortem histology. Clinical Kidney Journal, 16(10), 1664-1673. doi:10.1093/ckj/sfad113
  3. 3. Belhaj, A., Dewachter, L., Monier, A., Vegh, G., Rorive, S., Remmelink, M., Closset, M., Melot, C., Creteur, J., Salmon, I., & Rondelet, B. (2023). Beneficial Effects of Tacrolimus on Brain-Death-Associated Right Ventricular Dysfunction in Pigs. International Journal of Molecular Sciences (CD-ROM), 24(13), 10439. doi:10.3390/ijms241310439
  4. 4. Belhaj, A., Dewachter, L., Hupkens, E., Remmelink, M., Galanti, L., Rorive, S., Melot, C., Naeije, R., & Rondelet, B. (2022). Tacrolimus Prevents Mechanical and Humoral Alterations in Brain Death-induced Lung Injury in Pigs. American journal of respiratory and critical care medicine, 206(5), 584-595. doi:10.1164/rccm.202201-0033OC
  5. 5. Rusu, S., Verocq, C., Trepant, A.-L., Maris, C., De Nève, N., Blanchard, O., Van Campenhout, C., De Clercq, S., Rorive, S., Cotoi, O. S., Decaestecker, C., Salmon, I., & D'Haene, N. (2021). Immunohistochemistry as an accurate tool for the assessment of BRAF V600E and TP53 mutations in primary and metastatic melanoma. Molecular and clinical oncology, 15(6), 270. doi:10.3892/mco.2021.2432
  6. 6. Mauri, F., Schepkens, C., Lapouge, G., Drogat, B., Song, Y., Pastushenko, I., Rorive, S., Blondeau, J., Golstein, S., Bareche, Y., Miglianico, M., Nkusi, E., Rozzi, M., Moers, V., Brisebarre, A., Raphael, M., Dubois, C., Durdu, B., Ribeiro, F., Sotiriou, C., Salmon, I., Vakili, J., Blanpain, C., Mauri, F., Schepkens, C., Lapouge, G., Drogat, B., Song, Y., Pastushenko, I., Rorive, S., Blondeau, J., Golstein, S., Bareche, Y., Miglianico, M., Nkusi, E., Rozzi, M., Moers, V., Brisebarre, A., Raphael, M., Dubois, C., Durdu, B., Ribeiro, F., Sotiriou, C., Salmon, I., Vakili, J., & Blanpain, C. (2021). NR2F2 controls malignant squamous cell carcinoma state by promoting stemness and invasion and repressing differentiation. Nature Cancer, 2(11), 1152-1169. doi:10.1038/s43018-021-00287-5
  7. 7. Lebrun, L., Bizet, M., Melendez Asensio, B., Alexiou, B., Absil, L., Van Campenhout, C., D'Haene, N., Rorive, S., Fuks, F., Decaestecker, C., & Salmon, I. (2021). Analyses of DNA Methylation Profiling in the Diagnosis of Intramedullary Astrocytomas. Journal of neuropathology and experimental neurology, 80(7), 663-673. doi:10.1093/jnen/nlab052
  8. 8. Bogaert, B., Tulelli, B., Rodesch, M., Pregardien, C., Rorive, S., & Lingier, P. (2021). Urachal mucinous cystadenoma in infant: First case report in infant and review of literature. Journal of Pediatric Surgery Case Reports, 71, 101942. doi:10.1016/j.epsc.2021.101942
  9. 9. Minsart, C., Rorive, S., Lemmers, A., Quertinmont, E., & Gustot, T. (2020). N-acetylcysteine and glycyrrhizin combination: Benefit outcome in a murine model of acetaminophen-induced liver failure. World Journal of Hepatology, 12(9), 596-618. doi:10.4254/WJH.V12.I9.596
  10. 10. Remmelink, M., De Mendonça, R., D'Haene, N., De Clercq, S., Verocq, C., Lebrun, L., Lavis, P., Racu, M.-L., Trepant, A.-L., Maris, C., Rorive, S., Goffard, J.-C., De Witte, O., Peluso, L., Vincent, J. L., Decaestecker, C., Taccone, F., & Salmon, I. (2020). Unspecific post-mortem findings despite multiorgan viral spread in COVID-19 patients. Critical care, 24(1), 495. doi:10.1186/s13054-020-03218-5
  11. 11. Godin, L., Balsat, C., Van Eycke, Y.-R., Allard, J., Royer, C., Remmelink, M., Pastushenko, I., D'Haene, N., Blanpain, C., Salmon, I., Rorive, S., & Decaestecker, C. (2020). A Novel Approach for Quantifying Cancer Cells Showing Hybrid Epithelial/Mesenchymal States in Large Series of Tissue Samples: Towards a New Prognostic Marker. Cancers, 12(4), 906. doi:10.3390/cancers12040906
  12. 12. Gevaert, T., Van Eycke, Y.-R., Vanden Broeck, T., Van Poppel, H., Salmon, I., Rorive, S., Muilwijk, T., Claessens, F., De Ridder, D., Joniau, S., & Decaestecker, C. (2020). The potential of tumour microenvironment markers to stratify the risk of recurrence in prostate cancer patients. PloS one, 15(12), e0244663. doi:10.1371/journal.pone.0244663

  13. << Précédent 1 2 3 4 5 6 7 8 9 10 11 12 Suivant >>